Retroperitoneal fibrosis – a report of five cases
Data publikacji online: 18-07-2017
Reumatologia 2017;55(3):140-144
Retroperitoneal fibrosis (RPF) is a rare disease, characterized by inflammation and deposition of fibrotic tissue in the vicinity of the abdominal aorta and iliac arteries. We present a report of five patients admitted to our department between January 2014 and February 2017, diagnosed with RPF. Abdominal pain was the most common presenting symptom; however, in one patient, RPF was identified accidentally in routinely performed ultrasonography. In 4 cases, corticosteroids (CS) in combination with azathioprine were applied as first-line therapy, whereas one patient was treated with intravenous methylprednisolone pulses followed by oral CS. In this paper, clinical features as well as laboratory and radiographic findings together with management and treatment outcomes in patients with RPF are discussed. Given the rarity of the condition, it seems important to report every single case of RPF to help establish its management algorithm.
Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367: 241-251.
Alberici F, Palmisano A, Urban ML, et al. Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis 2013; 72: 1584-1586.
Yachoui R, Sehgal R, Carmichael B. Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis. Clin Rheumatol 2016; 35: 401-407.
Minocha P, Setia A. Presentation of idiopathic retroperitoneal fibrosis at a young age: A rare case report. Intractable Rare Dis Res 2016; 5: 294-296.
Wolski H, Seremak-Mrozikiewicz A, Woyciechowska A, et al. Retroperitoneal fibrosis – case report and literature review. Ginekol Pol 2015; 86: 867-871.
Corradi D, Maestri R, Palmisano A, et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int 2007; 72: 742-753.
Alberti C. Revisiting the retroperitoneal fibroses: Are there any significant news about their aetiopathogenesis and diagnostic approaches? Eur Rev Med Pharmacol Sci 2012; 16: 1078-1094.
Khosroshahi A, Carruthers MN, Stone JH, et al. Rethinking Ormond’s Disease. Medicine 2013; 92: 82-91.
Zen Y, Onodera M, Inoue D, et al. Retroperitoneal Fibrosis: A Clinicopathologic Study With Respect to Immunoglobulin G4. Am J Surg Pathol 2009; 33: 1833-1839.
Koo BS, Koh YW, Hong S, et al. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Mod Rheumatol 2014; 7595: 1-5.
Fry AC, Singh S, Gunda SS, et al. Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: A retrospective study. Nephron Clin Pract 2008; 108: 213-220.
Kardar AH, Kattan S, Lindstedt E, et al. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 2002; 168: 550-555.
van Bommel EFH, Siemes C, Hak LE, et al. Long-Term Renal and Patient Outcome in Idiopathic Retroperitoneal Fibrosis Treated With Prednisone. Am J Kidney Dis 2007; 49: 615-625.
Marcolongo R, Tavolini IM, Laveder F, et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 2004; 116: 194-197.
Průcha M, Kolombo I, Štádler P. Combination of steroids and azathioprine in the treatment of Ormond’s disease – a single centre retrospective analysis. Prague Med Rep 2016; 117: 34-41.
Binder M, Uhl M, Wiech T, et al. Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann Rheum Dis 2012; 71: 311-312.
Moroni G, Gallelli B, Banfi G, et al. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Nephrol Dial Transplant 2006; 21: 2485-2490.
Kermani TA, Crowson CS, Achenbach SJ, et al. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 2011; 86: 297-303.
Urban ML, Palmisano A, Nicastro M, et al. Idiopathic and secondary forms of retroperitoneal fibrosis: A diagnostic approach. Rev Med Interne 2015; 36: 15-21.
Shiber S, Eliakim-Raz N, Yair M. Retroperitoneal fibrosis: case series of five patients and review of the literature. Rev Bras Reumatol 2016; 56: 101-104.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top